发布于: 公告转发:0回复:0喜欢:0
$Melinta Therapeutics(MLNT)$ 8-K - Current report Filed: 2019-02-25 AccNo: 0001193125-19-049056 Size: 977 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantItem 3.02: Unregistered Sales of Equity SecuritiesItem 3.03: Material Modifications to Rights of Security HoldersItem 5.01: Changes in Control of RegistrantItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接